Article

RPB awards $4.8M in grants to supporteye research

New York-Research to Prevent Blindness (RPB), announced 44 new grants totaling $4.8 million for investigations into the causes, treatment, and prevention of all blinding diseases.

New York-Research to Prevent Blindness (RPB), announced 44 new grants totaling $4.8 million for investigations into the causes, treatment, and prevention of all blinding diseases.

In the past 18 months, RPB has committed more than $12.9 million to eye research.

Across the United States, RPB-supported laboratories are investigating the entire spectrum of eye disease: from cataract, glaucoma, and diabetic reti-nopathy to age-related macular degeneration, retinitis pigmentosa, and eye movement disorders.

The latest awards were given to 29 medical institutions, including unrestricted and challenge grants to depart-ments of ophthalmology at 22 medical schools and 22 awards to individual scientists.

The recently-approved grant projects include:

Among RPB's vision scientists fighting eye diseases are nine active Jules and Doris Stein RPB Professors who receive $375,000 each over 5 years and up to $100,000 in a matching grant for laboratory construction.

An additional $150,000 may be awarded during a 2-year extension of the award.

RPB currently supports eye research at 54 medical institutions throughout the United States.

For a complete listing of grant recipients, go to http://www.rpbusa.org. OT

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.